IAA
HUMA icon

Independent Advisor Alliance’s Humacyte HUMA Stock Holding History

Independent Advisor Alliance’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Sell
14,500
-12,000
-45% -$11.1K ﹤0.01% 1049
2026
Q1 		$16.1K Buy
26,500
+12,000
+83% +$12.5K ﹤0.01% 1586
2025
Q4 		$13.9K Sell
14,500
-21,740
-60% -$30.8K ﹤0.01% 995
2025
Q3 		$63.1K Buy
36,240
+11,991
+49% +$23.5K ﹤0.01% 923
2025
Q2 		$50.7K Buy
24,249
+13,757
+131% +$26.4K ﹤0.01% 871
2025
Q1 		$17.9K Buy
+10,492
New +$39.4K ﹤0.01% 804

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Independent Advisor Alliance's HUMA Position: Q2 2026 in Review

Independent Advisor Alliance reduced its Humacyte (HUMA) stake by 45% in Q2 2026, selling an estimated $11.1K and leaving 14,500 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Independent Advisor Alliance first reported a position in HUMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $63.1K in Q3 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Independent Advisor Alliance held 14,500 shares of Humacyte worth $11.3K as of Q2 2026.
  • Independent Advisor Alliance sold 12,000 Humacyte shares in Q2 2026, an estimated $11.1K.
  • Humacyte made up ﹤0.01% of Independent Advisor Alliance's portfolio in Q2 2026, its #1049 holding.
  • Independent Advisor Alliance first reported a position in Humacyte in Q1 2025 and has held it in 6 quarters since.
  • Independent Advisor Alliance's Humacyte position peaked at $63.1K in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.